James Mond
2013
In 2013, James Mond earned a total compensation of $320.5K as Chief Scientific and Medical Officer at ADMA Biologics, a 64% decrease compared to previous year.
Compensation breakdown
| Bonus | $53,560 |
|---|---|
| Salary | $266,900 |
| Total | $320,460 |
Mond received $266.9K in salary, accounting for 83% of the total pay in 2013.
Mond also received $53.6K in bonus.
Rankings
In 2013, James Mond's compensation ranked 10,669th out of 12,286 executives tracked by ExecPay. In other words, Mond earned more than 13.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,669 out of 12,286 | 13th |
Division Manufacturing | 3,978 out of 4,612 | 14th |
Major group Chemicals And Allied Products | 1,255 out of 1,462 | 14th |
Industry group Drugs | 990 out of 1,156 | 14th |
Industry Biological Products, Except Diagnostic Substances | 161 out of 196 | 18th |
Source: SEC filing on April 29, 2014.
Mond's colleagues
We found two more compensation records of executives who worked with James Mond at ADMA Biologics in 2013.
News
ADMA Biologics CEO Adam Grossman's 2021 pay jumps 122% to $4.4M
April 28, 2022
ADMA Biologics CEO Adam Grossman's 2020 pay rises 15% to $2M
April 7, 2021
ADMA Biologics CEO Adam Grossman's 2019 pay rises 10% to $1.7M
April 29, 2020
ADMA Biologics CEO Adam Grossman's 2018 pay falls 42% to $1.6M
April 24, 2019